2784

Alfresa Holdings Corporation

アルフレッサホールディングス株式会社
Wholesale Trade
Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is also involved in the operation of dispensing pharmacies and conducting related businesses; ethical pharmaceuticals wholesaling business; self-medication products wholesaling business; and other medical-related businesses. In addition, the company manufactures and markets active pharmaceutical ingredients; contract distribution services in hospitals; operation, maintenance, and development of information system; supply of cell raw materials; manufacturing of specific processed cells and regenerative medicine products. The company was incorporated in 2003 and is based in Tokyo, Japan.
← Companies
Price
¥2,235
Market Cap
¥407.2B
Ent. Value
¥244.2B
Net Cash
¥163.1B
Shares Out.
182.2M
P / E
9.7×
EV / EBIT
6.8×
P / Book
0.80×
P / NCAV
2.54×
Div. Yield
1.52%
Financials
Metric FY 2025
TDnet 		FY 2024
EDINET ↗ 		FY 2023
EDINET ↗ 		FY 2022
EDINET ↗ 		FY 2021
EDINET ↗
Net Sales ¥3,104.1B ¥2,961.1B ¥2,858.5B ¥2,696.1B ¥2,585.6B
Cost of Sales — ¥2,747.1B ¥2,652.1B ¥2,504.0B ¥2,398.2B
Gross Profit — ¥213.9B ¥206.4B ¥192.1B ¥187.5B
SG&A — ¥175.8B ¥167.9B ¥161.9B ¥158.4B
Operating Income ¥36.2B ¥38.1B ¥38.5B ¥30.1B ¥29.1B
Non-Operating Income — ¥3.3B ¥3.0B ¥3.1B ¥4.1B
Dividend Income — ¥1.8B ¥1.6B ¥1.6B ¥2.2B
Interest Income — ¥144M ¥59M ¥56M ¥64M
Non-Operating Expenses — ¥942M ¥1.5B ¥440M ¥573M
Interest Expense — ¥279M ¥132M ¥64M ¥73M
Ordinary Income ¥38.6B ¥40.5B ¥40.0B ¥32.8B ¥32.6B
Pre-tax Income — ¥39.4B ¥43.8B ¥38.6B ¥48.2B
Income Taxes — ¥11.9B ¥14.2B ¥12.8B ¥16.0B
Current Tax — ¥13.3B ¥14.0B ¥13.2B ¥15.9B
Deferred Tax — ¥-1.4B ¥211M ¥-402M ¥97M
Net Income (owners) ¥41.7B ¥27.4B ¥29.6B ¥25.8B ¥32.2B
Minority Interest — ¥46M ¥15M ¥2M ¥20M
Comprehensive Income — ¥25.4B ¥39.0B ¥27.6B ¥8.5B
EBITDA — ¥53.0B ¥52.0B ¥43.5B ¥41.9B
Goodwill Amort. (J-GAAP) — ¥499M ¥498M ¥498M ¥624M
EPS ¥229.64 ¥147.54 ¥154.13 ¥127.42 ¥153.57
Shares Outstanding — 182.2M 187.3M 202.5M 202.5M
Shares Issued (total) — 191.3M 202.8M 202.8M 235.0M
Treasury Shares — 9.1M 15.5M 0.3M 32.5M